Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2024 ∙ Zhang, J. Lian, Z. Xue, X. Li, J. Zhu, Y. Huang, N. Xie, W.
Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination
All age groups Pregnant women Human papillomavirus (HPV) Safety Administration
Rating:
Critically low
2024 ∙ Kaur, H. Chauhan, A. Mascarenhas, M.
Does SARS Cov-2 infection affect the IVF outcome - A systematic review and meta-analysis
All age groups Pregnant women COVID-19 Safety
Rating:
Low
2024 ∙ Valeriani, F. Protano, C. Pozzoli, A. Vitale, K. Liguori, F. Liguori, G. Galle, F.
Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis
All age groups Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Yeh, Y. T. Tsai, T. F.
Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review
Adults Older adults COVID-19 Tuberculosis Safety
Rating:
Critically low
2024 ∙ Skare, T. L. de Carvalho, J. F. de Medeiros, I. R. T. Shoenfeld, Y.
Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Burch, E. Khan, S. A. Stone, J. Asgharzadeh, A. Dawe, J. Ward, Z. Brooks-Pollock, E. Christensen, H.
Early mathematical models of COVID-19 vaccination in high-income countries: a systematic review
All age groups COVID-19 Modeling
Rating:
Not applicable
2024 ∙ Chang, E. Li, H. Zheng, W. Zhou, L. Jia, Y. Gu, W. Cao, Y. Zhu, X. Xu, J. Liu, B. You, M. Liu, K. Wang, M. Huang, W.
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis
All age groups COVID-19 Economic aspects
Rating:
Not applicable
2024 ∙ Bawa, S. Wondimu, A. Postma, M. J. Hutubessy, R. van Hulst, M.
Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence
Newborn Children Adolescents Measles Economic aspects Administration
Rating:
Not applicable
2024 ∙ Zeinab, D. Shahin, N. Fateme, M. Saeed, B. F.
Economic evaluation of vaccination against COVID-19: A systematic review
All age groups COVID-19 Economic aspects
Rating:
Not applicable
2024 ∙ Vasconcelos, D. A. Santos, A. M. D. Nascimento, J. C. Silva, Ctds Menezes, A. F. Barreiro, Mdsc Ferreira, C. B. T. Silva, G. M.
Educational interventions for the prevention and management of adverse events following immunisation: a systematic review
Healthcare workers Safety
Rating:
Not applicable
Loading...